Diabetes Advocacy Alliance Applauds Proposal Providing Medicare Coverage for National Diabetes Prevention Program
March 23, 2016
The Diabetes Advocacy Alliance (DAA) applauds Secretary Sylvia Burwell, the Department of Health and Human Services (HHS) and the Center for Medicare and Medicaid Innovation (CMMI) for their proposal today which would expand coverage for the National Diabetes Prevention Program (National DPP) to eligible Medicare beneficiaries. The National DPP is an evidence-based lifestyle change program for preventing type 2 diabetes which is led by the Centers for Disease Control and Prevention (CDC).
Click here to view DAA's press release.
Representatives Ed Whitfield (R-KY) and Diana DeGette (D-CO), current Co-chairs of the Congressional Diabetes Caucus, announce that Whitfield will step down as Co-chair and be replaced by Representative Tom Reed (R-KY)
December 9, 2015
The DAA welcomes Congressman Tom Reed as the new Co-chair of the Congressional Diabetes Caucus. Reed has served as the Caucus’ Vice Chair for the past five years and has been a tireless advocate for people with diabetes and those at risk of developing the disease. Congressman Reed takes over as Co-chair from Congressman Ed Whitfield who is retiring at the end of the current session of Congress. The DAA looks forward to working together with Representative Reed, DeGette and members of the Diabetes Caucus to advance issues important to all Americans affected by this devastating disease.
Click here to view DAA's press release.
American Medical Association and CDC announce new joint initiative targeted to reach physicians and care teams that engage with adult patients at risk for type 2 diabetes.
March 12, 2015
Tthe American Medical Association (AMA) and the Centers for Disease Control and Prevention (CDC) launched a new initiative called "Prevent Diabetes STAT: Screen, Test, Act - Today™." The initiative is the latest effort by the AMA to raise awareness about prediabetes and the CDC's evidence-based diabetes prevention program. It is part of the AMA's ongoing Improving Health Outcomes initiative to prevent type 2 diabetes.
The first phase of the initiative is focused on providing physicians and care teams with easy-to-use tools and resources so they can identify people with prediabetes and refer them to community-based or virtual diabetes prevention programs.
According to the AMA's new release:
Prevent Diabetes STAT: Screen, Test, Act - Today™, is a multi-year initiative that expands on the robust work each organization has already begun to reach more Americans with prediabetes and stop the progression to type 2 diabetes, one of the nation's most debilitating chronic diseases. Through this initiative, the AMA and CDC are sounding an alarm and shining a light on prediabetes as a critical and serious medical condition.
"It's time that the nation comes together to take immediate action to help prevent diabetes before it starts," said AMA President Robert M. Wah, M.D. "Type 2 diabetes is one of our nation's leading causes of suffering and death—with one out of three people at risk of developing the disease in their lifetime. To address and reverse this alarming national trend, America needs frontline physicians and other health care professionals as well as key stakeholders such as employers, insurers, and community organizations to mobilize and create stronger linkages between the care delivery system, our communities, and the patients we serve."
"The time to act is now. We need a national, concerted effort to prevent additional cases of type 2 diabetes in our nation – and we need it now," said Ann Albright, Ph.D., R.D., director of CDC's Division of Diabetes Translation. "We have the scientific evidence and we've built the infrastructure to do something about it, but far too few people know they have prediabetes and that they can take action to prevent or delay developing type 2 diabetes."
To read the complete AMA news release, click here.
Interventions Lower Diabetes Risk in Women Who Had Gestational Diabetes
February 23, 2015
Women with a history of gestational diabetes face a heightened risk of developing Type 2 diabetes for years after giving birth, but intensive lifestyle intervention or a medication regimen can have a protective effect in this population, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Gestational diabetes is a form of diabetes that occurs during pregnancy, typically in the second trimester. The condition causes glucose levels in the bloodstream to rise above normal levels. Gestational diabetes occurs among as many as 9.2 percent of pregnant women, according to the U.S. Centers for Disease Control and Prevention.
"Our long-term follow-up study found the elevated risk of developing type 2 diabetes persisted for years in women who had been diagnosed with gestational diabetes, and this long-term risk can be reduced with either intensive lifestyle intervention or the medication metformin," said one of the study's authors, Vanita Aroda, MD, of the MedStar Health Research Institute in Hyattsville, MD.
Click here to read the complete news release from the Endocrine Society.
DAA Press Statement on USPSTF Draft Diabetes Screening Recommendation Diabetes Advocacy Alliance Applauds New U.S. Preventive Services Task Force Draft Diabetes Screening Guideline
October 9, 2014
The Diabetes Advocacy AllianceTM (DAA) applauds the United States Preventive Services Task Force's (USPSTF) new draft recommendation that would encourage health care professionals to screen for diabetes and prediabetes in all adults with risk factors for the disease. The DAA also expresses appreciation for the Task Force's comprehensive and thoughtful review of the evidence that supports the new screening guideline.
Adoption and use of this recommendation, which received a B rating, could help address the diabetes epidemic in America by identifying more of the estimated 86 million adults at risk for diabetes who could then be referred to evidence-based diabetes prevention programs in their communities that have been recognized by the Centers for Disease Control and Prevention's (CDC) National Diabetes Prevention Program. The screening guideline could also help identify more of the 8 million adults with undiagnosed diabetes who could receive appropriate treatment and care.Download Press Release
Continued Epidemic Rise in Diabetes and Prediabetes Shows Need for Immediate Congressional Action
June 19, 2014
In light of startling new data from the Center for Disease Control and Prevention's (CDC) National Diabetes Statistics Report, 2014, which show the relentless rise of diabetes and prediabetes in America, the Diabetes Advocacy Alliance(DAA) urges Congress to pass the National Diabetes Clinical Care Commission Act (H.R. 1074/S 539) this Congressional session.Download Press Release
Diabetes Advocacy Alliance Announces New Partnership With Department of Health and Human Services to Promote Diabetes Prevention and Treatment
November 19, 2012
Washington DC – The Diabetes Advocacy Alliance™ (DAA), a coalition of patient advocacy organizations, professional societies, trade associations, nonprofit organizations, and corporations announced today a new strategic partnership with the U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion (ODPHP). The partnership is designed to help meet the Healthy People 2020 diabetes prevention and treatment milestones.Download Press Release
Diabetes Coalition Expresses Concern Over Hill Efforts to Weaken Prevention and Public Health Fund
May 8, 2012
WASHINGTON DC – Calling the Prevention and Public Health Fund vital to slowing the diabetes epidemic in the US, the Diabetes Advocacy Alliance (DAA)—a coalition of 19 diabetes-related organizations representing patients, providers, and educators, among others—said today that Congress should keep the Prevention and Public Health Fund (Fund) intact.Download Press Release
Diabetes Advocacy Alliance Applauds Funding for CDC Program to Prevent Diabetes
February 16, 2012
(WASHINGTON) The Diabetes Advocacy Alliance™ (DAA) today applauded the Department of Health and Human Services for approving $10 million in funding for the CDC's National Diabetes Prevention Program (NDPP), an initiative that provides local communities with lifestyle change programs for preventing type 2 diabetes.
New Perspectives on Diabetes Screening Recommendation
January 10, 2012
In a press release issued today, the DAA supports arguments for expanded screening criteria for diabetes, made by scholars at The Lewin Group, in a peer-reviewed paper published in the January 2012 issue of Health Affairs.Download Press Release
DAA Applauds Action of Healthy People 2020
October 31, 2011
In this press release, the DAA applauds the Department of Health and Human Services and its Healthy People 2020 program for including a diabetes control measure as one the 26 Leading Health Indicators for the health of America.
Diabetes Advocacy Alliance: Broad Coalition Formed to Help Address Growing Health, Economic Threats from Diabetes Epidemic
New Website to serve as resource for policy change
June 15, 2011
(WASHINGTON) As part of its fundamental mission to inform policymakers about the severity of the US diabetes epidemic and offer sound solutions, the Diabetes Advocacy Alliance™ (DAA) today launched www.diabetesadvocacyalliance.org, a Website that will help serve as a resource for diabetes-related news and policy information.
Capitol Hill Briefing Set For May 10
Diabetes Advocacy Alliance to Raise Awareness of the Costs, Complications, and Potential Solutions to Predicted Diabetes Epidemic
May 03, 2011
(WASHINGTON) By 2025, the number of people with diabetes will swell by 64% to more than 50 million Americans in all, according to projections by the Institute for Alternative Futures. The costs will swamp the health care system, with a price tag of almost $514 billion – an amount comparable to the total budget of today's Medicare program and a 72% increase from 2010.
Journalists and bloggers that are interested in learning more about the Diabetes Advocacy Alliance™, or are interested in an interview with one of the co-chairs of the DAA, should contact:
Diabetes Advocacy Alliance